FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:2146 May 19, 2005 Number 20 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

By Jerrold S. Meyer and Linda F. Quenzer. 555 pp., illustrated. Sunderland, Mass., Sinauer Associates, 2005. $72.95. ISBN 0-87893-534-7.

In the preface to this book, the authors point out that for thousands of years humans have used psychoactive substances to modify their perceptions and mood. Indeed, some observers believe that such behavior may be a defining characteristic of the human condition. In contrast to the millennial history of drug taking, the era of scientific psychopharmacology is very short; perhaps its proper beginning can be dated to the middle of the 20th century. Since then, the rate of accrual of new knowledge in the field has increased enormously.

The authors aim to produce an introductory textbook on psychopharmacology and to . . . [Full Text of this Article]

This article has been cited by other articles:

• Al-Khatib, S. M., Greiner, M. A., Peterson, E. D., Hernandez, A. F., Schulman, K. A., Curtis, L. H. (2008). Patient and Implanting Physician Factors Associated With Mortality and Complications Following Implantable Cardioverter-Defibrillator Implantation, 2002-2005: Al-Khatib - Patient and Physician Factors and ICD Outcomes.. Circ Arrhythm Electrophysiol 1: 240-249 [Abstract] [Full Text]  
• Simpson, C. S. MD (2007). Implantable cardioverter defibrillators work so why aren't we using them?. CMAJ 177: 49-51 [Full Text]